You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

12 April 2018

India could shift from efavirenz to dolutegravir for HIV treatment – at no extra cost, new research suggests

Researchers recommend dolutegravir (DTG)‐based antiretrovirals should become the first option for HIV treatment in India, following a study into DTG’s cost-effectiveness.

17 November 2017

Immediate HIV treatment drastically reduces mortality in China

Immediate antiretroviral treatment (ART) for people with low CD4 counts in China reduces overall mortality by 63% – confirming trials in other countries that have shown the benefit of early treatment for improved health outcomes.

03 May 2017

India to provide free treatment for all people living with HIV

The country with the third largest HIV epidemic moves to a test-and-treat strategy that aims to get everyone on antiretroviral therapy.

05 January 2016

ARVs added to India’s National Essential Medicines List

HIV drugs should now be more accessible in India, after the country’s National List of Essential Medicines (NLEM) was expanded to include antiretrovirals (ARVs) and many other medicines.